← Open Payments lookup

KESHA MIMMS: Open Payments

NPI 1609343391 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$700 in 24 payments from 8 companies in 2025. Trend: 2023 $500 · 2024 $384 · 2025 $700

Food & beverage: $700
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.6$214
Neurocrine BioSciences, Inc.5$163
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$135
ABBVIE INC.3$73
Alkermes, Inc.2$48
Janssen Pharmaceuticals, Inc1$24
E.R. Squibb & Sons, L.L.C.1$22
Axsome Therapeutics, Inc.1$21

Products named: INGREZZA, ABILIFY MAINTENA, CAPLYTA, VRAYLAR, REXULTI, ARISTADA, INVEGA SUSTENNA, COBENFY.

Industry payments across HI — which companies pay providers there.